US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist

118.130
+0.370+0.31%

Close Nov 25 16:00 ET

119.000
+0.870+0.74%

Post 20:01 ET

204.89BMarket Cap35.91P/E (TTM)

Abbott Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

44.11%2.71B

62.93%1.96B

-10.32%1.03B

-24.21%7.26B

30.61%3.04B

-32.48%1.88B

-50.08%1.2B

-44.65%1.14B

-9.04%9.58B

-24.16%2.33B

Net income from continuing operations

14.62%1.65B

-5.31%1.3B

-7.06%1.23B

-17.45%5.72B

54.31%1.59B

0.07%1.44B

-31.86%1.38B

-46.14%1.32B

-1.95%6.93B

-48.06%1.03B

Operating gains losses

----

-41.40%126M

----

290.91%215M

----

Depreciation and amortization

-2.79%801M

0.63%805M

-0.12%805M

-0.73%3.24B

0.74%813M

1.10%824M

-2.68%800M

-2.07%806M

-7.66%3.27B

-8.61%807M

Other non cash items

87.71%-22M

121.21%140M

30.48%-748M

----

-352.11%-179M

-817.39%-660M

-424.88%-1.08B

----

Change In working capital

150.78%163M

3.60%-428M

-201.61%-561M

-62.94%-2.48B

-1,436.84%-1.52B

-195.54%-321M

33.13%-444M

85.75%-186M

-97.02%-1.52B

207.55%114M

-Change in receivables

87.64%-57M

-65.82%-325M

-164.81%-151M

-423.53%-356M

-80.06%68M

-186.98%-461M

-4.26%-196M

131.03%233M

82.25%-68M

280.42%341M

-Change in inventory

57.14%220M

58.47%-103M

2.15%-410M

83.58%-232M

256.08%295M

172.16%140M

47.90%-248M

24.37%-419M

-209.87%-1.41B

-1,360.00%-189M

-Change in prepaid assets

----

-622.67%-542M

----

75.96%-75M

----

-Change in payables and accrued expense

----

-280.95%-760M

----

-67.39%420M

----

-Change in other working capital

----

-52.74%-585M

----

57.82%-383M

----

Cash from discontinued investing activities

Operating cash flow

44.11%2.71B

62.93%1.96B

-10.32%1.03B

-24.21%7.26B

30.61%3.04B

-32.48%1.88B

-50.08%1.2B

-44.65%1.14B

-9.04%9.58B

-24.16%2.33B

Investing cash flow

Cash flow from continuing investing activities

6.31%-594M

62.65%-453M

8.01%-425M

-80.06%-3.13B

-30.38%-824M

-30.99%-634M

-359.47%-1.21B

-28.33%-462M

13.35%-1.74B

5.81%-632M

Net PPE purchase and sale

0.71%-556M

-5.13%-533M

-4.74%-398M

-23.92%-2.2B

-23.77%-755M

-19.91%-560M

-33.77%-507M

-18.38%-380M

5.73%-1.78B

0.65%-610M

Net business purchase and sale

--0

----

-1,843.75%-837M

--0

---51M

----

190.57%48M

--0

Net investment purchase and sale

-5.26%-40M

-2.53%77M

67.44%-28M

-251.52%-116M

-136.67%-71M

-80.95%-38M

33.90%79M

-109.76%-86M

65.63%-33M

56.52%-30M

Net other investing changes

-86.67%2M

100.00%2M

-75.00%1M

0.00%22M

-75.00%2M

275.00%15M

-87.50%1M

100.00%4M

-15.38%22M

-33.33%8M

Cash from discontinued investing activities

Investing cash flow

6.31%-594M

62.65%-453M

8.01%-425M

-80.06%-3.13B

-30.38%-824M

-30.99%-634M

-359.47%-1.21B

-28.33%-462M

13.35%-1.74B

5.81%-632M

Financing cash flow

Cash flow from continuing financing activities

32.65%-1.58B

38.63%-791M

16.60%-1.18B

7.14%-7.09B

-40.84%-2.05B

-51.65%-2.34B

-58.55%-1.29B

63.12%-1.41B

-38.99%-7.64B

22.75%-1.46B

Net issuance payments of debt

102.86%43M

1,233.33%160M

-202.38%-127M

-254.08%-2.48B

-9,490.00%-939M

-6,375.00%-1.51B

20.00%12M

94.35%-42M

-181.85%-699M

105.10%10M

Net common stock issuance

-37,450.00%-751M

99.30%-3M

58.15%-226M

67.67%-1.23B

62.19%-259M

99.75%-2M

-8,420.00%-426M

76.59%-540M

-65.07%-3.8B

29.67%-685M

Cash dividends paid

-8.11%-960M

-7.98%-961M

-7.53%-957M

-7.46%-3.56B

-7.90%-888M

-7.51%-888M

-7.49%-890M

-6.97%-890M

-3.34%-3.31B

-3.13%-823M

Proceeds from stock option exercised by employees

64.29%92M

-13.33%13M

116.13%134M

0.00%167M

-17.07%34M

-1.75%56M

50.00%15M

5.08%62M

-34.51%167M

-50.00%41M

Cash from discontinued financing activities

Financing cash flow

32.65%-1.58B

38.63%-791M

16.60%-1.18B

7.14%-7.09B

-40.84%-2.05B

-51.65%-2.34B

-58.55%-1.29B

63.12%-1.41B

-38.99%-7.64B

22.75%-1.46B

Net cash flow

Beginning cash position

-10.82%6.99B

-31.40%6.28B

-30.22%6.9B

0.85%9.88B

-30.07%6.71B

-12.33%7.84B

19.36%9.16B

0.85%9.88B

43.30%9.8B

3.14%9.59B

Current changes in cash

148.77%535M

155.12%716M

20.99%-576M

-1,545.37%-2.96B

-31.65%162M

-245.68%-1.1B

-197.45%-1.3B

65.58%-729M

-93.24%205M

-53.53%237M

Effect of exchange rate changes

224.14%36M

51.85%-13M

-550.00%-36M

81.15%-23M

-50.98%25M

69.79%-29M

61.97%-27M

233.33%8M

-74.29%-122M

492.31%51M

End cash Position

12.65%7.56B

-10.82%6.99B

-31.40%6.28B

-30.22%6.9B

-30.07%6.71B

-12.33%7.84B

19.36%9.16B

0.85%9.88B

Free cash flow

63.17%2.15B

105.03%1.43B

-17.82%627M

-35.17%5.06B

33.04%2.28B

-43.06%1.32B

-65.73%696M

-56.25%763M

-9.76%7.8B

-30.04%1.72B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	44.11%2.71B	62.93%1.96B	-10.32%1.03B	-24.21%7.26B	30.61%3.04B	-32.48%1.88B	-50.08%1.2B	-44.65%1.14B	-9.04%9.58B	-24.16%2.33B
Net income from continuing operations	14.62%1.65B	-5.31%1.3B	-7.06%1.23B	-17.45%5.72B	54.31%1.59B	0.07%1.44B	-31.86%1.38B	-46.14%1.32B	-1.95%6.93B	-48.06%1.03B
Operating gains losses	----	----	----	-41.40%126M	----	----	----	----	290.91%215M	----
Depreciation and amortization	-2.79%801M	0.63%805M	-0.12%805M	-0.73%3.24B	0.74%813M	1.10%824M	-2.68%800M	-2.07%806M	-7.66%3.27B	-8.61%807M
Other non cash items	87.71%-22M	121.21%140M	30.48%-748M	----	----	-352.11%-179M	-817.39%-660M	-424.88%-1.08B	----	----
Change In working capital	150.78%163M	3.60%-428M	-201.61%-561M	-62.94%-2.48B	-1,436.84%-1.52B	-195.54%-321M	33.13%-444M	85.75%-186M	-97.02%-1.52B	207.55%114M
-Change in receivables	87.64%-57M	-65.82%-325M	-164.81%-151M	-423.53%-356M	-80.06%68M	-186.98%-461M	-4.26%-196M	131.03%233M	82.25%-68M	280.42%341M
-Change in inventory	57.14%220M	58.47%-103M	2.15%-410M	83.58%-232M	256.08%295M	172.16%140M	47.90%-248M	24.37%-419M	-209.87%-1.41B	-1,360.00%-189M
-Change in prepaid assets	----	----	----	-622.67%-542M	----	----	----	----	75.96%-75M	----
-Change in payables and accrued expense	----	----	----	-280.95%-760M	----	----	----	----	-67.39%420M	----
-Change in other working capital	----	----	----	-52.74%-585M	----	----	----	----	57.82%-383M	----
Cash from discontinued investing activities
Operating cash flow	44.11%2.71B	62.93%1.96B	-10.32%1.03B	-24.21%7.26B	30.61%3.04B	-32.48%1.88B	-50.08%1.2B	-44.65%1.14B	-9.04%9.58B	-24.16%2.33B
Investing cash flow
Cash flow from continuing investing activities	6.31%-594M	62.65%-453M	8.01%-425M	-80.06%-3.13B	-30.38%-824M	-30.99%-634M	-359.47%-1.21B	-28.33%-462M	13.35%-1.74B	5.81%-632M
Net PPE purchase and sale	0.71%-556M	-5.13%-533M	-4.74%-398M	-23.92%-2.2B	-23.77%-755M	-19.91%-560M	-33.77%-507M	-18.38%-380M	5.73%-1.78B	0.65%-610M
Net business purchase and sale	--0	----	----	-1,843.75%-837M	--0	---51M	----	----	190.57%48M	--0
Net investment purchase and sale	-5.26%-40M	-2.53%77M	67.44%-28M	-251.52%-116M	-136.67%-71M	-80.95%-38M	33.90%79M	-109.76%-86M	65.63%-33M	56.52%-30M
Net other investing changes	-86.67%2M	100.00%2M	-75.00%1M	0.00%22M	-75.00%2M	275.00%15M	-87.50%1M	100.00%4M	-15.38%22M	-33.33%8M
Cash from discontinued investing activities
Investing cash flow	6.31%-594M	62.65%-453M	8.01%-425M	-80.06%-3.13B	-30.38%-824M	-30.99%-634M	-359.47%-1.21B	-28.33%-462M	13.35%-1.74B	5.81%-632M
Financing cash flow
Cash flow from continuing financing activities	32.65%-1.58B	38.63%-791M	16.60%-1.18B	7.14%-7.09B	-40.84%-2.05B	-51.65%-2.34B	-58.55%-1.29B	63.12%-1.41B	-38.99%-7.64B	22.75%-1.46B
Net issuance payments of debt	102.86%43M	1,233.33%160M	-202.38%-127M	-254.08%-2.48B	-9,490.00%-939M	-6,375.00%-1.51B	20.00%12M	94.35%-42M	-181.85%-699M	105.10%10M
Net common stock issuance	-37,450.00%-751M	99.30%-3M	58.15%-226M	67.67%-1.23B	62.19%-259M	99.75%-2M	-8,420.00%-426M	76.59%-540M	-65.07%-3.8B	29.67%-685M
Cash dividends paid	-8.11%-960M	-7.98%-961M	-7.53%-957M	-7.46%-3.56B	-7.90%-888M	-7.51%-888M	-7.49%-890M	-6.97%-890M	-3.34%-3.31B	-3.13%-823M
Proceeds from stock option exercised by employees	64.29%92M	-13.33%13M	116.13%134M	0.00%167M	-17.07%34M	-1.75%56M	50.00%15M	5.08%62M	-34.51%167M	-50.00%41M
Cash from discontinued financing activities
Financing cash flow	32.65%-1.58B	38.63%-791M	16.60%-1.18B	7.14%-7.09B	-40.84%-2.05B	-51.65%-2.34B	-58.55%-1.29B	63.12%-1.41B	-38.99%-7.64B	22.75%-1.46B
Net cash flow
Beginning cash position	-10.82%6.99B	-31.40%6.28B	-30.22%6.9B	0.85%9.88B	-30.07%6.71B	-12.33%7.84B	19.36%9.16B	0.85%9.88B	43.30%9.8B	3.14%9.59B
Current changes in cash	148.77%535M	155.12%716M	20.99%-576M	-1,545.37%-2.96B	-31.65%162M	-245.68%-1.1B	-197.45%-1.3B	65.58%-729M	-93.24%205M	-53.53%237M
Effect of exchange rate changes	224.14%36M	51.85%-13M	-550.00%-36M	81.15%-23M	-50.98%25M	69.79%-29M	61.97%-27M	233.33%8M	-74.29%-122M	492.31%51M
End cash Position	12.65%7.56B	-10.82%6.99B	-31.40%6.28B	-30.22%6.9B	-30.22%6.9B	-30.07%6.71B	-12.33%7.84B	19.36%9.16B	0.85%9.88B	0.85%9.88B
Free cash flow	63.17%2.15B	105.03%1.43B	-17.82%627M	-35.17%5.06B	33.04%2.28B	-43.06%1.32B	-65.73%696M	-56.25%763M	-9.76%7.8B	-30.04%1.72B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data